Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents
Crossref DOI link: https://doi.org/10.1007/s00432-015-2026-y
Published Online: 2015-08-28
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xue, Kai
Gu, Juan J.
Zhang, Qunling
Mavis, Cory
Hernandez-Ilizaliturri, Francisco J.
Czuczman, Myron S.
Guo, Ye
Text and Data Mining valid from 2015-08-28